Sofosbuvir, Velpatasvir, and Voxilaprevir
1 NDC across 1 manufacturer|0 Generic,1 Brand
▸ More about this market▾ Less
Sofosbuvir, Velpatasvir, and Voxilaprevir is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $858.69 to $858.69 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$858.69 – $858.69
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VOSEVI 400-100-100 MG TABLET | $858.6884 per EA | — |
Frequently Asked Questions
How many Sofosbuvir, Velpatasvir, and Voxilaprevir products are on the market?
The Sofosbuvir, Velpatasvir, and Voxilaprevir drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Sofosbuvir, Velpatasvir, and Voxilaprevir?
NADAC reference prices for Sofosbuvir, Velpatasvir, and Voxilaprevir range from $858.6884 to $858.6884 per EA.
Which manufacturers make Sofosbuvir, Velpatasvir, and Voxilaprevir?
1 manufacturer lists Sofosbuvir, Velpatasvir, and Voxilaprevir in NADAC. Ranked by number of NDCs, the largest are Gilead Sciences, Inc. (1).